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Abstract
The human parvovirus Adeno-Associated Virus (AAV) type 2 can only replicate in cells co-infected with a helper virus, such
as Adenovirus or Herpes Simplex Virus type 1 (HSV-1); whereas, in the absence of a helper virus, it establishes a latent
infection. Previous studies demonstrated that the ternary HSV-1 helicase/primase (HP) complex (UL5/8/52) and the single-
stranded DNA-Binding Protein (ICP8) were sufficient to induce AAV-2 replication in transfected cells. We independently
showed that, in the context of a latent AAV-2 infection, the HSV-1 ICP0 protein was able to activate rep gene expression. The
present study was conducted to integrate these observations and to further explore the requirement of other HSV-1
proteins during early AAV replication steps, i.e. rep gene expression and AAV DNA replication. Using a cellular model that
mimics AAV latency and composite constructs coding for various sets of HSV-1 genes, we first confirmed the role of ICP0 for
rep gene expression and demonstrated a synergistic effect of ICP4 and, to a lesser extent, ICP22. Conversely, ICP27 displayed
an inhibitory effect. Second, our analyses showed that the effect of ICP0, ICP4, and ICP22 on rep gene expression was
essential for the onset of AAV DNA replication in conjunction with the HP complex and ICP8. Third, and most importantly,
we demonstrated that the HSV-1 DNA polymerase complex (UL30/UL42) was critical to enhance AAV DNA replication to a
significant level in transfected cells and that its catalytic activity was involved in this process. Altogether, this work
represents the first comprehensive study recapitulating the series of early events taking place during HSV-1–induced AAV
replication.
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Introduction
Adeno-Associated Virus (AAV) type 2 is a human parvovirus that
is widely used as a vector for gene transfer. Its 4.7 kb single-stranded
DNA genome contains two open reading frames, rep and cap,f l a n k e d
by Inverted Terminal Repeats (ITRs) that serve as origins of DNA
replication.FourRepproteinsareproducedfromtherepgene bytwo
different promoters and splicing patterns. The major Rep78 and
Rep68 proteins display DNA-binding, endonuclease, and helicase
activities that are essential for AAV genome replication. Three
structural proteins (VP1/2/3) are produced by the cap gene and
assemble to form the capsid [1]. Productive replication of wild-type
(wt) AAV depends upon the presence of a helper virus whereas, in its
absence, AAV enters latency. During this phase, the viral genome is
maintainedinan episomal orintegratedformandistranscriptionally
silent. Upon re-activation by infection with a helper virus, the set of
events leading to the production of infectious particles consists of the
early activation of the rep gene, the rescue of the AAV genome and
finally the generation of replicative DNA forms that also serve as
templates for Rep and Cap protein synthesis [2].
Early studies identified several different viruses as able to display
helper activities for AAV growth including Adenovirus (Ad) and
Herpes Simplex Virus type 1 (HSV-1). The helper functions of Ad
were extensively characterized and demonstrated to be supplied by
the E1a, E1b-55K, E2a, and E4Orf6 genes, and by the VA RNAs
[3]. Their main effects involve the induction of AAV gene
expression and viral genome replication. Importantly, the DNA
polymerase activity responsible for AAV replication in the
presence of Ad was demonstrated to be of cellular origin [4].
In contrast, the helper functions provided by HSV-1 have been
less extensively characterized. Early studies performed using sub-
genomic fragments of the HSV-1 genome identified several
immediate-early and early HSV-1 genes involved in the helper
effect [5]. However, because immediate-early factors are essential
for the expression of all subsets of HSV-1 genes when native
promoters are used, distinguishing between direct or indirect
helper effects was difficult. A more detailed analysis was conducted
by Weindler et al. who demonstrated replication of transfected
AAV-2 genomes using four HSV-1 genes coding for the helicase/
primase (HP) complex (UL5/UL8/UL52) and the single-stranded
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Further work showed that, upon cotransfection of UL5/UL8/
UL52, and UL29 expressing constructs, with a plasmid containing
the wild-type AAV genome, AAV DNA replicated in discrete
nuclear foci that co-localized with ICP8 and cellular replication
protein A (RPA) [7,8]. In this context, the UL52 primase activity
was demonstrated to be dispensable whereas, the UL5 helicase
activity was required [9]. Based on these results and on previous
studies on the formation of HSV-1 replication centers, the HP
proteins were proposed to constitute a scaffold that further recruits
ICP8, Rep proteins, and AAV DNA. This model assumed that
AAV DNA replication, which starts from a self-primed DNA
template would then be conducted by the combined effects of Rep
proteins, the HSV-1 helicase, ICP8, and cellular factors including
the DNA polymerases.
Two questions were not addressed in those studies. The first
concerned the role of HSV-1 DNA polymerase. Indeed, even if it
was clear that the HP complex and ICP8 could induce AAV
replication, the level achieved was less than 1% of that observed in
cells infected with wt HSV-1, suggesting that some critical factors
involved in DNA replication were missing [9]. A potential role for
the HSV-1 DNA polymerase had been previously suggested by
studies indicating that addition of phosphonoacetic acid (PAA)
greatly reduced AAV replication during co-infection with HSV-1
[10]. In addition, the involvement of the HSV-1 DNA polymerase
was further suggested by Ward et al. who demonstrated that this
viral complex could replicate AAV DNA using in vitro replication
assays in the absence of cellular factors [11]. However, despite
these observations the role of the polymerase was not re-evaluated
in vivo by adding it to the minimal set of HSV-1 helper factors.
The second unresolved question concerned the identification of
other HSV-1 helper proteins potentially involved in regulation of
AAV rep gene expression, a step essential to drive the virus into the
replication cycle, as exemplified by the helper effect provided by
the Ad E1A protein [12]. During natural AAV infection, the viral
genome is either introduced into the nucleus as a single-stranded
linear molecule by infection, or it is already present in a latent,
integrated form. In both situations a viral transactivator is required
to induce Rep protein synthesis. An initial study toward identifying
HSV-1 transactivating factors was performed by Geoffroy et al.
who demonstrated that the immediate-early ICP0 protein, which
is known for its ability to activate viral gene expression, could also
activate the transcription of the rep gene in cells latently infected
with wt AAV2 [13]. However, those studies also revealed that
other factors were still missing since when cells were infected with
an HSV-1 mutant with a deletion of the ICP0 gene a low level of
Rep proteins could still be detected (Figure S3). In addition, ICP0
expression alone was neither sufficient to induce Rep synthesis at
levels similar to those found during wt HSV-1 infection, nor able
to activate the expression of the AAV cap gene.
The present study was conducted to integrate the above
observations and to further explore the requirement for other
HSV-1 proteins during early AAV replication steps, i.e. rep gene
expression and AAV DNA replication. Using a cellular model that
mimics AAV latency and composite constructs encoding several
immediate-early and early HSV-1 proteins expressed under the
control of heterologous promoters, we first confirmed the role of
ICP0 for rep gene expression and further demonstrated a
synergistic effect of ICP4 and, to a lesser extent, of ICP22.
Conversely, the other HSV-1 immediate-early protein tested,
ICP27, was shown to have an inhibitory effect. Second, our
analyses indicated that the effect of ICP0, ICP4 and ICP22 on rep
gene expression was essential for the induction of AAV DNA
replication in conjunction with the HSV-1 HP complex and ICP8.
Third, and most importantly, our results indicated that the HSV-1
DNA polymerase complex (UL30/UL42) was critical to enhance
AAV DNA replication to a significant level in transfected cells and
that its catalytic activity was involved in this process. Altogether
this work represents the first comprehensive study recapitulating
the series of early events that take place during HSV-1-induced
AAV replication.
Results
The ICP0, ICP4, and ICP22 immediate-early HSV-1
proteins cooperate to activate AAV rep gene expression
from a latent integrated form
For this study we used a HeLa cell clone (HeLaAAVtCR) that
contained integrated in its DNA a modified AAV genome
composed of the AAV-2 ITRs flanking a rep gene in which the
rep ORF was fused at its 59 terminus with the fluorescent mCherry
coding sequence and two affinity tags (Figure 1A). The analysis of
this cell clone indicated that it contained approximately three
AAVtCR genome copies per cell with at least one of these copies
integrated into the AAVS1 locus (Figure S1). As previously
observed with latently infected HA-16 cells, infection of these cells
with wt HSV-1 led to the synthesis of the four Rep proteins, two of
which had the expected higher molecular weight due to their
fusion with mCherry and the two tags (Figure 1B) [13]. Most
importantly, HSV-1 infection also led to the formation of AAV
replicative forms, thereby indicating that the fused Rep proteins
(tCR78 and tCR68) were fully functional (Figure 1C). Further
studies also showed that the fused Rep proteins were fluorescent
and localized to the nucleus. These analyses demonstrated that the
HeLaAAVtCR cells constituted an appropriate model of AAV
latency that could be used to study the early steps of AAV
activation without any interference from the presence of the cap
gene and the synthesis of AAV particles [14].
TheHeLaAAVtCR clonewasfirstusedtoinvestigatethe effect of
HSV-1 immediate-earlyfactorsonrepgene activation. Ourprevious
studyhadindicatedthattheHSV-1ICP0 proteinwasabletoinduce
AAV rep gene expression from a latent integrated wt AAV genome
[13]. Accordingly, transfection of the HeLaAAVtCR cells with a
plasmid expressing ICP0 under the control of a CMV promoter led
to the synthesis of Rep proteins (Figure 2A). Transfection of
HeLaAAVtCR cells with plasmids expressing either ICP4 or ICP27
or ICP22, revealed that only ICP4 was able to activate rep gene
expression alone, although to a lesser extent than ICP0. More
Author Summary
The Adeno-Associated Virus (AAV) is a human parvovirus
that is widely used as a recombinant vector for gene
transfer in animal studies and clinical trials designed to
treat acquired or inherited genetic diseases. Wild type AAV
is defined as a defective virus because it requires the
presence of a helper virus to efficiently replicate. Although
many viruses can provide helper functions to AAV, only
those of Adenovirus were extensively studied, leading to
the generation of molecular tools for recombinant AAV
vector production. This study focuses on the helper
activities of another virus, the Herpes Simplex Virus type-
1 (HSV-1). We demonstrate that nine HSV-1 proteins are
able to fully and efficiently support the early steps of AAV
replication. As such, this study provides new information
critical for the understanding of AAV replication and also
opens the way for new biotechnological developments in
the field of recombinant AAV vectors.
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activation was also observed. Conversely, co-expression of ICP27
with ICP0 and ICP4 decreased the level of Rep proteins, in
particular tCRep78/68 and Rep 40, whereas co-expression of
ICP22 increased the level of Rep 52 and 40, in a very low but
reproducible manner (Figure 2A) (Figure S6). Similar results were
observed in cells transiently infected with wt AAV-2 particles
(Figure S2). We concluded from these experiments that ICP0, ICP4
and ICP22 were sufficient to induce an optimal level of Rep
proteins. Therefore, a plasmid combining the three expression
cassettes coding for ICP0, ICP4 and ICP22 was constructed using a
Gateway reaction (pTF3) (Figure 3A). Transfection of this construct
induced AAV Rep protein synthesis at a level comparable to that
observed upon co-transfection of the three individual plasmids
encoding for ICP0, ICP4, and ICP22 (Figure 2B). Altogether these
results confirmed the previously documented trans-activating
activity of ICP0 on rep gene expression and further demonstrated
a synergistic effect of ICP4 and, to a lesser extent, of ICP22, as well
as an inhibitory effect of ICP27.
Rep gene activation by ICP0, ICP4, and ICP22 is essential
to induce AAV DNA replication in the presence of UL5/
UL8/UL52 (HP) and ICP8
Previous studies indicated that the subset of HSV-1 genes able to
provide helper functions for AAV DNA replication included ICP8
and the HP complex [6,8,9]. Therefore, after having shown that
ICP0, ICP4, and ICP22 expressed by the pTF3 plasmid cooperate
to activate rep gene expression, we determined their effect on AAV
DNA replication either alone or in association with the previously
identified HSV-1 helper replication factors. For this, the UL5/8/52
and UL29 genes were cloned as independent expression cassettes in
a single plasmid, pRF, using the Gateway technology (Figure 3A).
Transfection of the pRF plasmid into HeLaAAVtCR cells indicated
that expression of these HSV-1 replication factors alone was not
sufficient to induce Rep synthesis or AAV DNA replication
(Figure 3B and 3C). In contrast, transfection of the pTF3 plasmid
induced Rep protein synthesis but no AAV replication. More
importantly, co-transfection of pTF3 with pRF increased Rep
synthesis and generated detectable replicative forms. These results
indicated that the three HSV-1transactivating factorswereessential
to induce AAV replication in association with the HP and ICP8
proteins. Nevertheless, in these conditions the level of Rep proteins
andAAVDNAreplicationremainedverylowcomparedtothelevel
observed in cells infected with HSV particles.
Effect of the HSV-1 polymerase
Because previous studies had documented a controversial role of
the DNA HSV-1 polymerase in AAV replication, we then tested its
impact on the induction of AAVtCR genome replication [6,10,11].
For this, the UL30 and UL42 genes, coding respectively for the
catalytic and regulatory subunits of the HSV-1 DNA polymerase
complex,were clonedasafusionopen readingframelinkedthrough
Figure 1. Characterization of the HeLaAAVtCR cell clone. (A) Schematic representation of the wt AAV-2 genome and of the AAVtCR derivative.
In the AAVtCR construct the rep gene is fused at its N-terminus with a sequence coding for the calmodulin and streptavidin binding peptides (C and
S) and the fluorescent mCherry protein. p5, p19, and p40 are the AAV promoters and the dotted line indicates the alternative splicing in the rep gene.
The black box indicates the BGH polyA. (B) Synthesis of Rep proteins in HSV-1-infected HeLaAAVtCR and HA-16 cells. The cells were infected or not
with wt HSV-1 at a multiplicity of infection (MOI) of 5 plaque forming units (pfu)/cell and analyzed for the synthesis of Rep proteins by Western blot.
tCR indicates the tagCherryRep78 and 68 proteins. (C) Analysis of AVVtCR genome rescue and replication. Replication was assessed by Southern blot
using a rep probe. mRF and dRF indicate the monomeric and dimeric replicative forms, respectively.
doi:10.1371/journal.ppat.1000340.g001
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(pPol) or inserted through a Gateway reaction in the above
mentioned pTF3 plasmid (pTF3Pol) (Figure 3A). Surprisingly,
addition of the UL30/UL42 genes to factors encoded by the pTF3
and pRF plasmids strongly increased Rep synthesis as well as the
level of AAVtCR replication (Figure 3B and 3C). Similarly,
transfection of the pPol plasmid was able to complement, at least
partially, the reduced ability of an HSVDUL30 mutant virus to
induce AAVtCR replication as compared with wt HSV-1 infection
(Figure 3C).A similar effectwasalsoobserved usingan HSVDUL42
mutant virus (Figure S5). Quantification of this effect by qPCR
indicated that addition of UL30/UL42 to the other HSV-1 factors
(pTF3 and pRF) or to HSVDUL30 mutant virus induced, on
average, a 60- and 11-fold increase in AAV DNA replication,
respectively (Figure 3D). To further demonstrate a role for the
HSV-1 DNA polymerase, a plasmid encoding for an UL30 protein
with a G885A mutation in its catalytic domain was generated. The
characterization of this mutant, which was previously documented
to lack any detectable DNA polymerase activity [15,16], indicated
that the protein was still able to localize to the nucleus (Figure 4A).
In addition, the mutated UL30 protein was not only unable to
rescue the growth of the HSVDUL30 virus (data not shown), but
also incapable of stimulating AAVtCR genome replication and Rep
protein expression when co-transfected with the pTF3 and pRF
plasmids (Figure 4B and 4C). Similar results were also obtained
using a different cell clone containing an integrated AAV genome
composed of the rep gene fused to mCherry and a flag tag (data not
shown). Altogether, these results indicated that, in the context of an
integrated and latent AAVtCR genome, the optimal combinationof
HSV-1 factors required to induce efficient Rep synthesis and AAV
DNA replication included the ICP0, ICP4, ICP22 immediate-early
factors, as well as the UL5/UL8/UL52, UL29 and UL30/UL42
early regulatory proteins. In addition, these results demonstrated for
the first time the involvement of the HSV-1 DNA polymerase
catalytic activity in in vivo AAV replication.
Visualization of AAV replication centers induced by HSV-
1 proteins
Previous studies have demonstrated that in transfected cells, the
HSV-1 ICP8 protein and HP complex assemble into discrete foci
that can be visualized by a punctuate ICP8 staining [17,18]. In
addition, Rep was demonstrated to interact with ICP8, and to be
recruited into ICP8-containing foci formed during wt HSV-1 and
AAVco-infection[7,8]. Consequently, to correlate ourresults to the
formation of AAV replication centers, transfected HeLaAAVtCR
cells were examined for the intranuclear localization of the Rep and
ICP8 proteins. Consistent with the results presented in Figure 2 and
3, transfection with the pTF3 plasmid led to Rep protein synthesis
visualized as a weak diffuse intra-nuclear fluorescence without ICP8
staining whereas transfection of pRF alone led to the typical ICP8
punctuate staining pattern but no Rep synthesis (Figure 5A, upper
line). Co-transfection of pTF3 and pRF promoted re-localization of
a fraction of the Rep proteins in small and large foci that co-
localized with ICP8, clearly evoking pre-replication and replication
centers, respectively (Figure 5A, lower left). Expression of the HSV-
1 DNA polymerase (UL30/UL42), in addition to the latter HSV-1
factors, resulted in the formation of larger ICP8 foci that co-
localized with Rep proteins (Figure 5A, lower right). FISH analysis
of these foci with a probe recognizing rep DNA showed the presence
of AAV DNA co-localizing with Rep proteins both in cells infected
with HSV-1 or transfected with pTF3pol/pRF, thus confirming the
identification of these foci as true AAV replication centers
(Figure 5B). These results confirmed that the co-transfection of
two plasmids encoding nine HSV-1 proteins (UL5/UL8/UL52,
UL29, UL30/42, ICP0, ICP4 and ICP22) resulted in the formation
of AAV replication centers.
Finally, to easily monitor AAV replication in cells, we took
advantage of the visualization system previously developed by
Fraefel et al. [19]. This method relies on the detection of AAV
replication by co-transfecting cells with a rAAV vector containing
numerous Lac0 binding sites and a second plasmid encoding a
fluorescent LacI binding protein. Using this method, rAAV
replication foci that co-localized with Rep proteins were observed
upon transfection of pTF3 and pRF plasmids. Also, co-expression
of the UL30/UL42 genes generated larger replication centers
within the nucleus that co-localized with ICP8 (Figure 5C, upper
line). Finally, these analyses indicated, for the first time, the co-
localization of ICP0, ICP4 and UL30 proteins with replicating
rAAV DNA, further supporting their involvement in AAV
replication (Figure 5C, middle and lower line).
Figure 2. Analysis of Rep protein synthesis upon transfection with plasmids encoding HSV-1 immediate-early proteins. HeLaAAVtCR
cells were transfected with the indicated plasmids and harvested 48 h later. (A) Cell lysates were analyzed by Western blot with an anti-Rep antibody
(303.9) and, after stripping of the membrane, with an anti-tubulin antibody. (B) Comparison of Rep synthesis following either co-transfection with
ICP0, ICP4, and ICP22 expressing plasmids or with the pTF3 construct. After analysis with an anti-Rep antibody, the membranes were stripped and re-
probed with anti-ICP0, anti-ICP4, and anti-tubulin antibodies.
doi:10.1371/journal.ppat.1000340.g002
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Wt AAV-2 is defined as a defective virus because it requires the
presence of a helper virus to efficiently replicate. Understanding
the nature of the helper functions provided by different viruses is
essential to identify the cellular factors that control the AAV life
cycle. It is also important to provide new tools and strategies for
the development of rAAV vectors. The objective of this study was
to integrate some previous observations regarding the HSV-1
helper activities and to further explore the requirement for other
HSV-1 proteins during early steps in AAV replication. Using a
cellular model that mimics AAV latency and composite constructs
encoding several HSV-1 proteins, we demonstrated that nine
HSV-1 immediate-early and early proteins are required to
efficiently sustain the early steps of the AAV replicative cycle
including expression of the rep gene and viral DNA replication.
Rep gene activation by HSV-1 immediate-early proteins
The present results confirm our previous observation that ICP0
is able to activate rep gene expression and also extend this property
to the ICP4 protein [13]. In contrast, ICP27 is shown to be
dispensable and, in many experiments, inhibitory for Rep protein
synthesis. This latter result is in accordance with previous studies
indicating that the ICP27-defective HSV-1 strain can be used for
high-titer rAAV productions [20,21]. The main question raised by
these observations concerns the mechanism involved in the
transactivating effect exerted by ICP0 and ICP4. How rep gene
repression is maintained during latency is unknown. Current
knowledge indicates that ICP0 activates gene expression without
binding DNA but rather acts by the modification and/or the
degradation of some cellular factors [22]. We have previously
demonstrated that the transactivating activity of ICP0 on the p5
Figure 3. Induction of Rep protein synthesis and AAVtCR genome replication by combinations of HSV-1 immediate-early and early
genes. (A) Schematic view of the HSV-1 constructs pTF3, pRF, and pTF3Pol. Each plasmid encodes three to four HSV-1 orfs expressed under the
control of heterologous promoters and polyA signals. The arrow heads indicate the following heterologous promoters: CMV (black), TK (light grey),
PGK (dark grey), short eIF1-a (striped box). The rectangles correspond to the following polyA signals: SV40 (black), TK (light grey), b-Globin (dark grey),
and synthetic polyA (striped box). The grey areas between each gene correspond to the GatewayH recombination signals used to obtain these
constructs. CcdB is a selection marker used to screen bacterial colonies. The white box indicates the ampicillin resistance gene. (B) HeLaAAVtCR cells
were either transfected with different combinations of HSV-1 derived plasmids, or infected with wt HSV-1 or HSVDUL30 (MOI of 5 pfu/cell). (C)
Analysis of AAVtCR genome replication. Genomic DNA was extracted and analyzed by Southern blot with a rep probe. Upper image: undigested
DNA; lower image: Pst I digested DNA. Digestion with Pst I was used to resolve all the AAVtCR replication products into a unique 1.4 kb band. (D)
Analysis of AAVtCR genome replication by qPCR using primers located in the AAV rep gene. The quantity of rep sequences in each condition was
determined as described in the Materials and Methods and presented as the fold enrichment relative to a cellular genomic sequence on chromosome
X. The data shown are mean values with error bars representing the standard error of the mean for three independent experiments.
doi:10.1371/journal.ppat.1000340.g003
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ubiquitin ligase activity [13,23]. Therefore, it is possible that the
effect of ICP0 on the AAV p5 promoter might be mediated
through the specific degradation of some unidentified repressor. In
this study, we additionally demonstrated that ICP4 can also
activate rep gene expression, albeit at a lower level than ICP0, and
that it synergistically acts with ICP0 to increase the level of Rep
proteins. Such an effect was not unexpected since previous studies
had documented that ICP0 and ICP4 can physically interact and
cooperatively activate the expression of a variety of HSV-1 and
heterologous promoters, including some cellular ones [24–27].
The ICP4 protein is essential to activate the expression of HSV-1
early and late genes and it represses its own transcription as well as
that of other immediate-early genes [28,29]. Although repression
by ICP4 involves its binding to high affinity sites in the promoters
of target genes, the mechanisms of activation remains unclear
since strong ICP4 binding sites are not present in many viral
promoters [30,31]. In the case of the rep gene, a consensus ICP4
binding site has not been found. More recently, DeLuca and
colleagues have shown that the oligomerization of ICP4 molecules
was important for the transactivation of promoters containing
weak and degenerate binding sites, probably through the
recruitment of transcription factors such as TFIID and TAF250
[32,33]. Therefore, it is possible that the transactivating activity of
ICP4 on the p5 promoter is exerted by binding to degenerate and
weak binding sites that cannot be readily identified by sequence
analysis. In our study, we also documented a slight but
reproducible transactivating effect of ICP22. This factor, which
is required for the optimal expression of some HSV-1 late genes in
some non transformed cell lines, is apparently involved in the
alteration of cell cycle regulatory proteins and in the modification
of cellular RNA polymerase II [34,35]. Altogether, these
observations suggest that these three HSV-1 factors may act in
independent ways: the ICP0 protein appears to be the major
Figure 4. Effect of a mutated HSV-1 DNA polymerase on Rep protein synthesis and AAV DNA replication. (A) Intracellular localization of
the wt and mutated HSV-1 polymerase in HeLa cells. HeLa cells were co-transfected with pTF3 and pRF and either the pPol or pPolG885A plasmid.
48 h post-transfection the cells were fixed, stained with an anti-UL30 antibody and observed under a confocal microscope. Cell nuclei were stained
with Topro3. Bars: 2 mm (B) Analysis of Rep protein synthesis. HeLaAAVtCR cells were transfected with the indicated plasmids and, where indicated,
infected 24 h later with the appropriate HSV-1 strains at an MOI of 2 pfu/cells and harvested 24 h later. Cell lysates were analyzed by Western blot
with an anti-Rep antibody (303.9) and, after stripping of the membrane, with an anti-tubulin antibody. (C) Genomic DNA was analyzed by qPCR using
primers located in the AAV rep gene to measure AAVtCR replication. The amount of rep sequence in each condition was determined as described in
the Materials and Methods and presented as the fold enrichment relative to a cellular genomic sequence on chromosome X. The data shown are
mean values with error bars representing the standard error of the mean for three independent experiments.
doi:10.1371/journal.ppat.1000340.g004
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degradation and/or modification of a cellular repressor preventing
rep gene expression during latency; ICP4 may enhance this effect
by binding to some degenerate sites and recruiting cellular
transcription factors, and finally, ICP22 may influence rep gene
expression by acting on the cell cycle proteins.
Figure 5. Visualization and analysis of AAVtCR and rAAV replications centers. (A) Co-visualization of Rep and ICP8. HeLaAAVtCR cells,
transfected with the indicated plasmids, were fixed and stained with an anti-ICP8 antibody. Cell nuclei were stained with Topro3. The Rep signal was
provided by the expression of Rep proteins fused to mCherry (CRep). Bars: 2 mm. (B) Co-visualization by immuno-FISH analysis of AAVtCR DNA and
Rep proteins. HeLaAAVtCR cells were either infected with HSVDUL30 at an MOI of 5 pfu/cell or co-transfected with the pTF3pol and pRF plasmids and
fixed 48 or 24 h later, respectively. The AAVtCR DNA was visualized using a combination of four non overlapping DIG-labeled rep probes followed by
incubation with an anti-DIG antibody; Rep proteins were detected using an anti-Rep antibody (76.3). Cell nuclei were stained with Topro3. Bars: 2 mm.
(C) Co-visualization of rAAV DNA with either Rep, ICP4, UL29, or UL30 proteins. Vero cells were co-transfected with the indicated combinations of
HSV-1 plasmid, pAAVlacO, pSV2-EYFP/lacI, and p5CR (upper line) or p5Rep (middle and bottom line). Two days later cells were fixed and either
directly observed under a confocal microscope (top line) or stained for detection of ICP8, ICP0, ICP4, and UL30 using antibodies. Cell nuclei were
stained with DAPI. CRep: Cherry-Rep. Bars: 5 mm.
doi:10.1371/journal.ppat.1000340.g005
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HP– and ICP8–induced AAV DNA replication
Previous studies indicated that the HSV-1 HP complex and
ICP8 were sufficient to induce AAV replication in the absence of
any other HSV-1 gene [6,8,9]. Our results do not contradict these
findings but additionally demonstrate that, in the context of a
latent AAV genome, activation of the rep gene by ICP0, ICP4, and
ICP22 is an essential prerequisite to detect AAV DNA replication
upon transfection with plasmids coding for HP and ICP8. These
apparently discordant results can be explained by the fact that
most of the previous studies were conducted on cells transfected
with a plasmid containing the wt AAV-2 genome. In this situation
a transcriptional activator was not required since the rep gene is
transcriptionally active resulting in the synthesis of Rep proteins at
a level sufficient to initiate viral DNA replication. In contrast, in
our cell model like in other wt AAV-2 latently infected cell lines,
the integrated AAV genome is present in a repressed form that can
be rescued and replicated upon infection with a helper virus, such
as HSV-1. In this context, induction of rep gene expression via the
activation of the p5 promoter, constitutes the first event before
rescue of AAV DNA and DNA replication. As such, we believe
that this model is more appropriate to identify all the HSV-1
factors required during all the events of the AAV life cycle, as
exemplified in this study by the observed strict dependency upon
rep gene activation for AAV DNA replication. Importantly, this
strict dependency was only partially relieved when cells were
transfected with a plasmid coding for the rep gene, further
indicating that, even in this context, the presence of HSV-1
transcription factors is important to stimulate AAV replication
(data not shown).
Role of the HSV-1 DNA polymerase
Since the initial report describing the HSV-1 helper effect on
AAV replication, the role of the HSV-1 polymerase has
constituted a matter of debate. Indeed, studies conducted using
either HSV-1 strains encoding a thermosensitive DNA polymerase
or individual plasmids expressing the HSV-1 early replication
factors indicated that the HSV-1 polymerase was not essential to
achieve high levels of AAV DNA replication, further suggesting
that, in this situation, as in cells co-infected with Ad, AAV
exclusively used cellular polymerases to achieve replication of its
genome [6]. However, in vitro replication assays performed later by
Ward and colleagues indicated that the HSV-1 UL30/UL42
complex could replicate AAV DNA [11]. Our results confirm that
the HSV-1 UL30/UL42 DNA polymerase complex although not
strictly essential, is critical to significantly enhance AAV DNA
replication in vivo, in particular in the context of transfected cells.
Indeed, in cells infected with the HSVDUL30 mutant, the level of
AAVDNA replication was higher than in cells transfected with the
minimal set of transcription and replication factors (pTF3+pRF).
In addition, during infection the presence of the polymerase
significantly increased AAV DNA replication but did not result in
a higher level of Rep proteins (see Figure 3D versus 3C). A likely
explanation for this latter result is that, in infected cells, in the
presence of the HSV-1 DNA polymerase, AAV competes with
replicating HSV genomes in particular for the expression of its
viral genes. Consequently, enhancing the level of AAV DNA
templates does not result in a higher level of Rep proteins synthesis
thus explaining why this viral gene was not identified as a critical
factor in earlier studies. Altogether, these results highlight a
different requirement between infected and transfected cells: on
the one hand they confirm that the viral polymerase is not
essential, in particular in infected cells; on the other hand, they
indicate that in transfected cells the viral polymerase complex,
even if not strictly essential, is critical to achieve a high level of
replication and Rep proteins synthesis. Finally, in both infected
and transfected cells the HSV-1 polymerase catalytic activity is
shown to be required to activate AAV DNA replication. This
result indicates that the role of the polymerase cannot be restricted
to that of a scaffold protein required for the recruitment of cellular
factors in AAV replication centers [36,37].
A reconstituted model of HSV-1–induced AAV early
replication steps
In the case of Ad, five genes have been demonstrated to be
sufficient to induce a complete AAV replication cycle leading to
the production of infectious particles [3]. In contrast, this and
other studies indicated that the HSV-1 helper activities required
for AAV gene expression and genome replication, are shared
between at least nine genes, thus, reflecting a more complex
situation than in the case of Ad.
The model describing the sequential events involved in HSV-1-
induced AAV replication that arises from these findings is depicted
in Figure 6. In cells latently infected with AAV, all the viral genes
are in a repressed state. The first event required to activate AAV
replication occurs as the transactivation of rep gene expression.
This step is performed essentially by the HSV-1 immediate-early
factors that can act at the transcriptional and/or post-transcrip-
tional level. Induction of Rep synthesis results in a diffuse Rep
localization in the nucleus. Rescue of the integrated AAV genome
can occur either at this step or after the onset of AAV replication.
Indeed, previous studies of this phenomenon have indicated that it
can be performed either through the action of cellular nucleases
that excise the genome from the cellular chromosome or via a
replication-coupled mechanism [38–40]. The minimal complex
required for AAV DNA replication is composed of the HSV-1 HP
and ICP8 proteins that also constitute a scaffold for the formation
of replication centers that co-localize with Rep proteins and AAV
DNA. In these structures, AAV DNA is replicated through the
action of Rep proteins, the HSV-1 helicase (UL5), ICP8, and
cellular factors including the DNA polymerases. However, in
transfected cells, progression toward the formation of large
replication compartments depends upon the presence of the
HSV-1 DNA polymerase complex (UL30/UL42) that enhances
the level of AAV DNA synthesis. Further analyses are required to
determine whether this set of HSV-1 genes is also sufficient to
promote the formation of infectious AAV particles that implicates
the optimal expression of the cap gene and the packaging of AAV
genomes.
The main questions raised by this model concern the
mechanism and consequence of HSV-1 polymerase-induced
AAV DNA replication. Indeed, it remains to be established
whether the UL30/UL42-induced replication is conducted in
parallel with that induced by cellular polymerases or whether it
represents an alternative and exclusive pathway. In addition, it is
tempting to speculate that the recruitment of the HSV-1 DNA
polymerase in AAV replication centers is involved in the inhibition
of HSV-1 replication. Indeed, previous studies have shown that
AAV inhibits HSV-1 at the level of DNA replication in a dose
dependent manner [41]. Therefore the ability of AAV to use the
viral polymerase might explain, at least in part, its capacity to
interfere with HSV-1 propagation and promote its own replica-
tion. Analysis of the contribution of cellular and HSV-1
polymerase during the establishment of AAV replication centers
induced in the presence of HSV-1 particles or genes will help to
clarify these issues.
Altogether, these and future studies will be critical to get a better
insight into the AAV life cycle and, consequently, introduce new
HSV-1-Induced AAV Replication
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identification of the HSV-1 helper activities is expected to result
in the generation of new tools for the production of rAAV vectors,
such as HSV-derived helper plasmids or stable cell lines that could
combine elements from different helper viruses to optimally induce
the formation of rAAV particles.
Materials and Methods
Cells and viruses
African green monkey kidney fibroblasts (Vero), Human
cervical epithelial cells (HeLa), and derived cell lines were
maintained in Dulbecco’s modified Eagle’s medium (DMEM,
Sigma) supplemented with 10% fetal bovine serum (FCS,
HyClone) and 1% penicillin–streptomycin (5,000 U/ml, Invitro-
gen). The previously described HA-16 cell clone is derived from
HeLa cells latently infected wt AAV-2 [42]. The HeLaAAVtCR
cell clone was obtained by cotransfecting the pAAVtCR and
pPGK-Neo plasmids, the latter conferring resistance to G418 to
HeLa cells. Individual G418 resistant clones were screened for the
presence of AAV sequences by PCR and then tested for the
production of functional and fluorescent Rep proteins upon
infection with wt HSV-1. The HSV-1 viruses used in the study
were wt HSV-1 (17 syn+), HSVDUL30 (HP66) provided by D.
Coen (Harvard University, Boston, MA, USA). Wt and mutant
HSV stocks were produced and titrated by standard procedures on
Vero or PolB3 cells (provided by C. Hwang, SUNY Health
Science Center, Syracuse, NY, USA), respectively.
Plasmids
The pAAVtCR plasmid (Figure 2) was obtained by inserting the
mCherry ORF from pRSETmCherry (provided by Y. Tsien) and
the calmodulin and streptavidin binding peptide (CBP and SBP)
tags from pNTAP-A (Interplay Mammalian TAP system,
Stratagene) in a modified AAV-2 genome derived from the
pSSV9 plasmid [43] from which the cap gene had been removed
and replaced with the Bovine Growth Hormone (BGH) polyad-
enylation site (polyA). For the visualization of rAAV vector
replication, the rep gene was either expressed from p5CR,
encoding mCherry [44] fused to the N terminus of AAV
Rep68/78 under the control of the p5 promoter and unmodified
Rep52/40 under the control of the p19 promoter, or from p5Rep
producing unmodified Rep proteins under the control of the AAV
p5 promoter.
The HSV-1 plasmids used for this study are described in
Figure 3. They were obtained using the Multisite GatewayH Pro
System (Invitrogen) that uses a cloning method based on the
bacteriophage lambda site-specific recombination system to
facilitate the efficient construction of plasmids containing two to
four DNA elements [45]. The resulting HSV-1 plasmids contain
three or four HSV-1 cDNAs flanked by heterologous promoters
and polyadenylation signals (polyAs) and by specific Gateway
recombination signals. For the construction of these plasmids, first,
four combinations of promoters and polyA were cloned between
Xho I and Sac I sites of psp72 (Promega) to give rise to preA, preB,
preC and preD plasmids. These plasmids contained the Cyto-
megalovirus (CMV) promoter and SV40 polyA, the HSV-1
thymidine kinase (TK) promoter and polyA signal (TKpA), the
murine phosphoglycerate kinase-1 (PGK) promoter and the rabbit
b-globin polyA (bGpA), the short EIF1-a promoter (sEIFa) and a
synthetic polyA (spA), respectively. The primers used for this step
(sequence available upon request) created a PacI-AvrII-XbaI
multiple cloning site between the promoter and polyA signal and
inserted two Gateway recombination sites flanking the expression
cassette (Invitrogen). The preA, preB, preC and preD contained
the B1/B5r, B5/B4, B4r/B3r and B3/B2 Gateway recombination
signals and CMV/SV40, TK/TKpA, PGK/bGpA, and sEIFa/
spA promoter/polyA, respectively. To generate entry plasmids
suitable for use as substrates in a Gateway LR reaction, the preA,
preB, preC, and preD vectors were recombined using BP Clonase
II with the Multisite Gateway Pro Donor vectors pDONR221 P1-
P5r, pDONR221 P5-P4, pDONR221 P4r-P3r, and pDONR221
P3-P2, respectively. The resulting entry plasmids were named pA,
pB, pC, and pD and contained a PacI-AvrII-XbaI cloning site
where the HSV-1 genes were then inserted. The ICP0 and ICP4
coding sequences were obtained from plasmids pCi110 (provided
by R. Everett) and pCMVICP4, respectively. The other HSV-1
genes were amplified by PCR from the HSV-1 containing cosmids
cos6, cos14, cos 28, cos48 and cos56 [46] using the Phusion High-
Fidelity DNA polymerase (Finnzymes). The positions of the
amplified sequences on the wt HSV-1 genome (GenBank
no. NC_001806) were: UL5, 15,172–12,471 bp; UL8, 18,217–
20,507 bp; UL52, 109,029–112,231 bp; UL29: 62,091–
58,431 bp; UL54 (ICP27), 113,689–115,277 bp; US1 (ICP22),
132,608–133,919 bp. The UL30 and UL42 coding sequences
(UL30, 62,755–66,512, and UL42, 93,113–94,617 bp) were fused
using the Foot and Mouth Disease Virus autoprotease sequence
2A (FMDV2A in bold) using the following primers: UL30rev-: 59-
ttttttaagcttaagaaggtcaaaattcaacagctgtgctagagtatcaaaggctcta-39;
UL42for-: 59-tttttaagcttgcgggagacgtcgagtccaaccccgggcccat-
gacggattcccctggcgg-39. The Hind III site used to join the
sequences is underlined. The resulting coding sequence was
cloned in pB and pC giving rise to pBpol and pPol plasmids. Each
individual plasmid was sequenced to check for the absence of
mutations and a subset of these individual plasmids (pD-ICP4, pB-
CP27, pB-UL29, pB-pol, pPol, and p-UL52) were tested for their
Figure 6. Proposed model for HSV-I induced AAV replication
from a latently infected cell line. See the Discussion section for
details.
doi:10.1371/journal.ppat.1000340.g006
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mutation in the corresponding genes (Figure S4). Finally,
combinations of four entry plasmids were assembled into a unique
construct by a single GatewayH LR reaction using pDEST-14
(Invitrogen) as a destination vector. Reactions performed with pA-
UL5, pB-UL29, pC-UL8 and pD-UL52 gave rise to pRF; with
pA-ICP0, pB-pol, pC-ICP22, and pD-ICP4 to pTF3pol. pTF3
was obtained from pTF3pol after a BP reaction with pDONR221
P5-P4 which removed the pol gene. The properties of these three
plasmids were demonstrated to be similar to those of the
corresponding individual plasmids (data not shown). The previ-
ously described G885A mutation into region I of the HSV-1 DNA
polymerase UL30 was introduced into the plasmid pPol by site-
directed mutagenesis using Quikchange XL Mutagenesis kit
(Stratagene) [15,16]. Primers used were 59-cgcatcatctacgcggacacg-
gactcc-39 and its reverse complement (mutation underlined). The
presence of the mutation in the pPol plasmid was checked by
sequencing and the resulting plasmid was named pPolG885A.
Southern blot
For this and other analyses cells were seeded in a 6-well plate at
a density of 5610
5 cells per well. Two days later, the cells were
transfected using standard calcium-phosphate procedure and
either fixed or harvested 48 h later for genomic DNA extraction.
For the analysis, 2 to 4 mg of total DNA were digested with EcoR
V or Pst I, run on 1% agarose gel and transferred to a Hybond N+
membrane (GE Healthcare). The membrane was then hybridized
overnight to a digoxigenin (DIG)-labeled probe in EasyHyb
solution (Roche). DIG- labeled probes were synthesized using the
DIG PCR Probe Synthesis kit (Roche) following the manufactur-
er’s instructions. Probe size and DIG incorporation were checked
on 1% agarose gel. The 513 bp gfp probe used for Southern Blot
was obtained by PCR with primers GFP-F (59-cctgaagttcatctg-
cacca-39) and GFP-R (59-ttctcgttggggtctttgct-39). The 902 bp rep
probe was synthesized using primers Rep2 (59-cgagattgtgat-
taaggtcc-39) and Rep4 (59-ccgcatattggggatcgtac-39). After over-
night hybridization the membrane was processed following the
manufacturer’s instructions, incubated 5 min at RT with CDP-
star (Roche), and then exposed to an autoradiography film.
Quantitative PCR
Primers used for the qPCR reaction were: REP-F (59-
gcaagaccggatgttcaaat-39) and REP-R (59-cctcaaccacgtgatccttt-39);
ChrX-F (59-gacagtcagccgcatcttctt-39) and ChrX-R (59-agttaaaag-
cagccctggtga-39). For all reactions, 10 mLo f2 6 Platinum SYBR
Green qPCR Supermix Uracil DNA Glycosydase (UDG)
(Invitrogen) were used in a final volume of 20 mL (in a 96 well
tray, Applera), and a final concentration of 400 nM of each primer
pair. Approximately 15 ng of DNA were added in 5 mLo f
solution. Reactions were always set up in duplicate. Each PCR was
performed as follows: initial uracil DNA glycosylase decontami-
nation at 50uC for 2 min followed by a 10 min hot-start
denaturation at 95uC, and 40 amplification cycles (15 s at 95uC,
30 s at 60uC). The melting temperature of the final double-
stranded DNA products was determined by gradual heating from
60uCt o9 5 uC over 20 min. All qPCR reactions were performed
with the ABI PRISM 7000 Sequence Detection System apparatus
(Applera). Absolute amounts of Rep and ChrX amplicons in
arbitrary units were determined using dilutions of genomic DNA
from HeLaAAVtCR cells mock transfected with a GFP expressing
plasmid as a standard. Calculations were done as described by
Pfaffl et al. [47] The data are expressed as Rep/Chr.X ratio, that
was fixed at 1 for the HeLaAAVtCR mock transfected cells.
Western blot analysis
The cells were collected, washed in phosphate-buffered saline
(PBS) and lysed with RIPA buffer (20 mM Tris-HCl pH 7.4,
50 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.5% deoxy-
cholate, and 0.5% SDS) in the presence of a cocktail of protease
inhibitors (Roche). Proteins were loaded on 10% SDS poly-
acrylamide gels and then transferred to nitrocellulose membranes
(GE Healthcare). After saturation, the membranes were incubated
overnight at 4uC with the appropriate antibody diluted in blocking
buffer. The anti-ICP4 (ab6514), and anti-ICP0 (ab6513) mouse
monoclonal antibodies were purchased from Abcam (Cambridge,
United Kingdom) and used at a 1/2500 and 1/1000 dilution,
respectively. The anti-Rep 303.9 antibody mouse monoclonal
antibody was used at a 1/20 dilution. The anti-tubulin (T5168,
SIGMA) mouse monoclonal antibody was used at a 1/2000
dilution. After PBS washes, a horseradish peroxidase-conjugated
anti-mouse antibody (Dako) was applied to the membranes at a 1/
20000 dilution for 1 h at RT. Finally, the membranes were
incubated for 5 minutes with the enhanced chemiluminescence
reagent (West Dura, Pierce) and exposed to an autoradiography
film. When necessary, the membranes were stripped for 30 min at
60uC in Tris, 62.5 mM, 2% SDS, 0.1 M b-mercaptoethanol,
pH 6.8 and then probed with another primary antibody.
Immunofluorescence analysis
The cells were seeded on 10 mm-round glass slides, and all steps
were performed at RT unless otherwise indicated. The cells were
fixed in PBS, 4% paraformaldehyde (PFA) for 10 min and then
permeabilized with PBS, 0,5% Triton X-100 for 30 min. The cells
were incubated with PBST (PBS, 4% bovine serum albumin, 0,2%
Tween) for 30 min before incubation for 1 h at RT with the
appropriate antibody diluted in PBS-T. The monoclonal anti-ICP8
mouse antibody (ab20194, Abcam) was diluted 1/200 and the
monoclonal76.3anti-Repmouse antibody was used pure. Next, the
slideswerewashedinPBSTand thenincubatedwithanAlexaFluor
488 donkey anti-mouse antibody (Invitrogen) diluted 1/2000 in
PBS-T for1 hinthe dark.Aftertwo PBST andtwo PBSwashes,the
slides were incubated for 5 min with TOPRO-3 used at a 1/5,000
dilution (Invitrogen). After extensive washes, the coverslips were
mounted onto glass slides with Fluoromount-G (CliniSciences).
Images were collected on a Confocal Axioplan2 LSM510 (Zeiss).
Immuno-FISH analysis
Cells were fixed and permeabilized as indicated above. After
incubation with 0,1 N HCl in PBS for 3 min, the cells were treated
1 h at 37uC with 100 mg/mL of RNAse A in 26SSC followed by
two 26SSC washes. The slides were then equilibrated in 26SSC,
50% formamide (pH 7) for 30 min, and then eventually stored at
4uC. FISH was performed using a mixture of four non overlapping
DIG-labeled probes of 400–500 bp covering the rep gene
(sequences available upon request). DIG labeled probes were
precipitated with sodium acetate and ethanol, resuspended in
FISH Hybridization buffer (26SSC, 50% Formamide, 10%
Dextran Sulfate, pH 7) and then added to the coverslips that
were sealed on glass slides. After denaturation 3 min at 75uC, the
slides were incubated overnight at 37uC. After post-hybridization
washes, the samples were saturated with PBST for 30 min. The
primary sheep anti-DIG antibody (Roche) was diluted 1/4000 and
the anti-Rep antibody (76.3) was used undiluted. The secondary
donkey anti-sheep Alexa 488 and donkey anti-mouse Alexa 555
antibodies (Invitrogen) were used at a 1/4000 and 1/2000
dilution, respectively in PBS-T. After incubation with the primary
and secondary antibodies for 1 h at 37uC, the samples were
washed and the nuclei counterstained with Topro-3 at a 1/5000
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Fluoromount-G (CliniSciences). Images were collected using a
Confocal Axioplan2 LSM510 (Zeiss).
Visualization of rAAV replication centers
The visualization of rAAV replication was performed as
previously described [19]. Briefly, the day before transfection,
Vero cells were seeded on round 12 mm cover glasses in 24-well
plates at 10
5 cells/well. Cells were transfected using Lipofectamine
Plus reagent (Invitrogen). The amounts of individual plasmids used
for transfection were as follows: pAAVlacO, 25 ng; pSV2-EYFP/
lacI, p5Rep, and p5CR, 10 ng. Helper functions for rAAV
replication were provided by co-transfection with 50 ng of
pTF3pol and pRF, respectively. Cells were fixed 48 hours after
transfection and processed for immunofluorescence. The antibod-
ies used for these analyses were: anti-ICP0 (Abcam 6513), anti-
ICP4 (Advanced Biotechnologies 102-124-1), anti-ICP8 (Abcam
20193), and anti-UL30 (mABC-4, a kind gift from C. Knopf).
Nuclei were stained with DAPI. Confocal microscopy was
performed essentially as described previously [19].
Accession numbers
Rep68: NC_001401; YP_680422; (GeneID: 4192013)
Rep78: NC_001401; YP_680423; (GeneID: 1489608)
Rep40: NC_001401; YP_680424; (GeneID: 4192014)
Rep52: NC_001401; YP_680425; (GeneID:1489607)
UL5: NC_001806; NP_044606; (GeneID:2703420)
UL8: NC_001806; NP_044609; (GeneID:2703432)
UL52: NC_001806; NP_044655; (GeneID:2703423)
ICP8 (UL29): NC_001806; NP_044631; (GeneID:2703458)
ICP22 (US1): NC_001806; NP_044663; (GeneID:2703435)
ICP27 (UL54): NC_001806; NP_044657; (GeneID:2703426)
ICP0 (RL2): NC_001806; NP_044660; (GeneID:2703390)
ICP4 (RS1): NC_001806; NP_044662; (GeneID:2703392)
UL30: NC_001806; NP_044632; (GeneID:2703462)
UL42: NC_001806; NP_044644; (GeneID:2703407)
Human Chr.X: NT_079573
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Figure S1 Analysis of AAVtCR genome copy number and site-
specific integration in HeLaAAVtCR cells.
Found at: doi:10.1371/journal.ppat.1000340.s001 (0.96 MB TIF)
Figure S2 Hela cells were transfected with the indicated
plasmids and, 6 hours later, infected with wt AAV-2 particles at
an MOI of 1000 particles/cell.
Found at: doi:10.1371/journal.ppat.1000340.s002 (0.66 MB PPT)
Figure S3 HA-16 were either left untreated (-) or infected at the
indicated MOIs with either wt HSV or HSVDICP0 (dl1403).
Found at: doi:10.1371/journal.ppat.1000340.s003 (0.37 MB TIF)
Figure S4 Functional activity of the pPol plasmid.
Found at: doi:10.1371/journal.ppat.1000340.s004 (1.82 MB TIF)
Figure S5 Both UL30 and UL42 HSV polymerase subunits
enhance AAVtCR genome replication.
Found at: doi:10.1371/journal.ppat.1000340.s005 (1.31 MB PDF)
Figure S6 Quantification of the effects of HSV-1 immediate
early factor on rep gene expression.
Found at: doi:10.1371/journal.ppat.1000340.s006 (0.31 MB TIF)
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